Appointments

Prof. Osinbajo will help shape Africa’s presence in global health structures, design sustainable financing mechanisms for health systems, and promote regional manufacturing capabilities.

Pamba brings to the role a rich combination of frontline medical experience, executive leadership, and a proven track record of driving healthcare access across Africa.

Abdallah previously served as Chief Investment Officer and has maintained close involvement with Cambridge Health Group for several years.

She will oversee the pharmaceutical company’s operations across India, Bangladesh, Nepal, Sri Lanka, and Maldives while joining the Board of Boehringer Ingelheim India.

Dr. Ali has served as a board member of Amanat Holdings since November 2020, bringing more than twenty years of expertise in education and business development.

Dr. Musuva takes the helm following the departure of Dr. Tim Theuri, whose fixed-term contract as CEO concluded on February 8th, 2026.

Dr. Basson joins Variant Bio with more than 25 years of leadership experience spanning academic medicine, global pharmaceutical development, and biotechnology sectors.

The Board’s decision to extend Dr. Zoëga’s appointment reflects confidence in both his individual leadership and the broader executive team’s capabilities.

The newly appointed Secretary of State has established herself as a distinguished Senior Clinical Psychotherapist throughout her extensive career.